[1] Cruz-jentoft AJ, Sayer AA. Sarcopenia. Lancet, 2019, 393: 2636-2646.
[2] Cruz-jentoft A J, Bahat G, Bauer J, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing, 2019, 48: 16-31.
[3] 贾继东. 终末期肝病的诊疗现状. 中华肝脏病杂志, 2007,15: 401-402.
[4] Dasarathy S, Merli M. Sarcopenia from mechanism to diagnosis and treatment in liver disease. J Hepatol, 2016, 65: 1232-1244.
[5] Tandon P, Ney M, Irwin I, et al. Severe muscle depletion in patients on the liver transplant wait list: its prevalence and independent prognostic value. Liver Transpl, 2012, 18: 1209-1216.
[6] Paternostro R, Bardach C, Hofer BS, et al. Prognostic impact of sarcopenia in cirrhotic patients stratified by different severity of portal hypertension. Liver Int, 2021,41:799-809.
[7] Beer L, Bastati N, BA-Ssalamah A, et al. MRI-defined sarcopenia predicts mortality in patients with chronic liver disease. Liver Int, 2020, 40: 2797-2807.
[8] Lucidi C, Lattanzi B, Di Gregorio V, et al. A low muscle mass increases mortality in compensated cirrhotic patients with sepsis. Liver Int, 2018, 38: 851-857.
[9] Van Vugt JLA, Alferink LJM, Buettner S, et al. A model including sarcopenia surpasses the MELD score in predicting waiting list mortality in cirrhotic liver transplant candidates: A competing risk analysis in a national cohort. J Hepatol, 2018, 68: 707-714.
[10] Nardelli S, Lattanzi B, Merli M, et al. Muscle alterations are associated with minimal and overt hepatic encephalopathy in patients with liver cirrhosis. Hepatology, 2019, 70: 1704-1713.
[11] Bhanji RA, Moctezuma-velazquez C, DUARTE-ROJO A, et al. Myosteatosis and sarcopenia are associated with hepatic encephalopathy in patients with cirrhosis. Hepatol Int, 2018, 12: 377-386.
[12] Nardelli S, Lattanzi B, Torrisi S, et al. Sarcopenia is risk factor for development of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt placement. Clin Gastroenterol Hepatol, 2017, 15: 934-936.
[13] Praktiknjo M, Book M, Luetkens J, et al. Fat-free muscle mass in magnetic resonance imaging predicts acute-on-chronic liver failure and survival in decompensated cirrhosis. Hepatology, 2018, 67: 1014-1026.
[14] Kang SH, Jeong WK, Baik SK, et al. Impact of sarcopenia on prognostic value of cirrhosis: going beyond the hepatic venous pressure gradient and MELD score. J Cachexia Sarcopenia Muscle, 2018, 9: 860-870.
[15] Moctezuma-velazquez C, Ebadi M, Bhanji R A, et al. Limited performance of subjective global assessment compared to computed tomography-determined sarcopenia in predicting adverse clinical outcomes in patients with cirrhosis. Clin Nutr, 2019, 38: 2696-2703.
[16] Fujiwara N, Nakagawa H, Kudo Y, et al. Sarcopenia, intramuscular fat deposition, and visceral adiposity independently predict the outcomes of hepatocellular carcinoma. J Hepatol, 2015, 63: 131-140.
[17] Cheng TY, Lee PC, Chen YT, et al. Pre-sarcopenia determines post-progression outcomes in advanced hepatocellular carcinoma after sorafenib failure. Sci Rep, 2020, 10: 18375.
[18] Uojima H, Chuma M, Tanaka Y, et al. Skeletal muscle mass influences tolerability and prognosis in hepatocellular carcinoma patients treated with lenvatinib. Liver Cancer, 2020, 9: 193-206.
[19] Kobayashi A, Kaido T, Hamaguchi Y, et al. Impact of sarcopenic obesity on outcomes in patients undergoing hepatectomy for hepatocellular carcinoma. Ann Surg, 2019, 269: 924-931.
[20] Berardi G, Antonelli G, Colasanti M, et al. Association of sarcopenia and body composition with short-term outcomes after liver resection for malignant tumors. JAMA Surg, 2020, 155: e203336.
[21] Hamaguchi Y, Kaido T, Okumura S, et al. Preoperative visceral adiposity and muscularity predict poor outcomes after hepatectomy for hepatocellular carcinoma. Liver Cancer, 2019, 8: 92-109.
[22] Kalafateli M, Mantzoukis K, Choi Yau Y, et al. Malnutrition and sarcopenia predict post-liver transplantation outcomes independently of the model for end-stage liver disease score. J Cachexia Sarcopenia Muscle, 2017, 8: 113-121.
[23] Czigany Z, Kramp W, Bednarsch J, et al. Myosteatosis to predict inferior perioperative outcome in patients undergoing orthotopic liver transplantation. Am J Transplant, 2020, 20: 493-503.
[24] Hamaguchi Y, Kaido T, Okumura S, et al. Proposal for new selection criteria considering pre-transplant muscularity and visceral adiposity in living donor liver transplantation. J Cachexia Sarcopenia Muscle, 2018, 9: 246-254. |
